ID
38075
Descripción
BACKGROUND: Currently, there is no proven pharmacologic treatment for patients with the acute respiratory distress syndrome (ARDS). Great interest remains in the use of corticosteroids for the salvage of patients with severe acute lung injury in the early phase of their disease process, a situation that that has not been evaluated in most published trials. Dexamethasone has never been evaluated in ARDS in a randomized controlled fashion. HYPOTHESIS AND OBJECTIVES: The investigators hypothesize that adjunctive treatment with intravenous dexamethasone of patients with established ARDS might change the pulmonary and systemic inflammatory response and thereby will increase the number of ventilator-free days and will decrease the extremely high overall mortality. Our goal is to examine the effects of dexamethasone on length of duration of mechanical ventilation (assessed by number of ventilator-free days) and on mortality, in patients admitted into a network of Spanish intensive care units (ICUs) who still meet ARDS criteria at 24 hours after ARDS onset.
Palabras clave
Versiones (1)
- 15/9/19 15/9/19 -
Titular de derechos de autor
Dr. Negrin University Hospital
Subido en
15 de septiembre de 2019
DOI
Para solicitar uno, por favor iniciar sesión.
Licencia
Creative Commons BY-NC 3.0
Comentarios del modelo :
Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.
Comentarios de grupo de elementos para :
Comentarios del elemento para :
Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.
Dexamethasone for Acute Respiratory Distress Syndrome NCT01731795
Eligibility Criteria
- StudyEvent: ODM
Descripción
Exclusion Criteria
Alias
- UMLS CUI-1
- C0680251
Descripción
Pregnant or Lactating
Tipo de datos
boolean
Alias
- UMLS CUI [1,1]
- C0043210
- UMLS CUI [1,2]
- C0032961
- UMLS CUI [2,1]
- C0043210
- UMLS CUI [2,2]
- C0006147
Descripción
Other treatment protocol
Tipo de datos
boolean
Alias
- UMLS CUI [1,1]
- C0205394
- UMLS CUI [1,2]
- C1517586
- UMLS CUI [1,3]
- C0040808
- UMLS CUI [1,4]
- C0521115
Descripción
Brain death
Tipo de datos
boolean
Alias
- UMLS CUI [1]
- C0006110
Descripción
Terminal stage cancer or disease
Tipo de datos
boolean
Alias
- UMLS CUI [1,1]
- C0205088
- UMLS CUI [1,2]
- C0006826
- UMLS CUI [2,1]
- C0205394
- UMLS CUI [2,2]
- C0679247
Descripción
Do-not-rescuitate orders
Tipo de datos
boolean
Alias
- UMLS CUI [1]
- C0079252
Descripción
Immunocompromised
Tipo de datos
boolean
Alias
- UMLS CUI [1]
- C0085393
Descripción
Corticosteroids or immunosuppressive drugs
Tipo de datos
boolean
Alias
- UMLS CUI [1]
- C0239126
- UMLS CUI [2]
- C0021081
Descripción
24 hours since onset elasped
Tipo de datos
boolean
Alias
- UMLS CUI [1,1]
- C4699705
- UMLS CUI [1,2]
- C0687676
- UMLS CUI [1,3]
- C0243161
- UMLS CUI [1,4]
- C1550543
- UMLS CUI [1,5]
- C0332152
- UMLS CUI [1,6]
- C1511481
- UMLS CUI [1,7]
- C0205265
- UMLS CUI [1,8]
- C0087153
- UMLS CUI [1,9]
- C4533435
Descripción
COPD
Tipo de datos
boolean
Alias
- UMLS CUI [1,1]
- C0205082
- UMLS CUI [1,2]
- C0024117
Descripción
Congestive Heart Failure
Tipo de datos
boolean
Alias
- UMLS CUI [1]
- C0018802
Similar models
Eligibility Criteria
- StudyEvent: ODM
C0035222 (UMLS CUI [1,2])
C0683983 (UMLS CUI [1,3])
C0243161 (UMLS CUI [1,4])
C0199470 (UMLS CUI [2])
C1519316 (UMLS CUI [1,2])
C0030705 (UMLS CUI [1,3])
C0009797 (UMLS CUI [2,1])
C1519316 (UMLS CUI [2,2])
C0030701 (UMLS CUI [2,3])
C0032961 (UMLS CUI [1,2])
C0043210 (UMLS CUI [2,1])
C0006147 (UMLS CUI [2,2])
C1517586 (UMLS CUI [1,2])
C0040808 (UMLS CUI [1,3])
C0521115 (UMLS CUI [1,4])
C0006826 (UMLS CUI [1,2])
C0205394 (UMLS CUI [2,1])
C0679247 (UMLS CUI [2,2])
C0021081 (UMLS CUI [2])
C0687676 (UMLS CUI [1,2])
C0243161 (UMLS CUI [1,3])
C1550543 (UMLS CUI [1,4])
C0332152 (UMLS CUI [1,5])
C1511481 (UMLS CUI [1,6])
C0205265 (UMLS CUI [1,7])
C0087153 (UMLS CUI [1,8])
C4533435 (UMLS CUI [1,9])
C0024117 (UMLS CUI [1,2])